Tag Archives: Carl Icahn

Remember when pharma was about medicines, not earnings-per-share?

KEY TAKEAWAY: Bruce Grant, an industry veteran recently said on LinkedIn “shareholder value” and value to society (or even customers) are not the same thing. And when they are in direct opposition, as in “activist investor”-driven pharma M&A — which to date has generated billions in fees for investment bankers and capital gains for the aforementioned “activist investors”while consistently destroying the long-term value of the companies involved — it should be called out for the kind of antisocial parasitism that it is”. Continue reading